SIMONE STEWART: Open Payments
NPI 1740526011 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 22 payments from 7 companies in 2025. Trend: 2023 $571 · 2024 $1,377 · 2025 $706
Food & beverage: $706
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $309 |
| Lilly USA, LLC | 6 | $167 |
| Novo Nordisk Inc | 5 | $89 |
| Exact Sciences Corporation | 3 | $57 |
| ABBVIE INC. | 2 | $50 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $16 |
Products named: AIRSUPRA, BREZTRI, JARDIANCE, FARXIGA, Cologuard Collection Kit, Ozempic, UBRELVY, MOUNJARO.
Industry payments across TX — which companies pay providers there.
